Results 211 to 220 of about 396,333 (302)

Rapid and Visual Detection of Mycobacterium tuberculosis Complex Based on Multiplex Recombinase Polymerase Amplification

open access: yesiLABMED, EarlyView.
We developed an on‐site detection platform for rapid detection of Mycobacterium tuberculosis complex (MTBC) based on the IS1081 gene. The platform utilizes real‐time multiplex recombinase polymerase amplification (mRPA) to achieve a reaction time of less than 30 min.
Xiaoyan Tan   +5 more
wiley   +1 more source

Knowledge transmission, culture and the consequences of social disruption in wild elephants. [PDF]

open access: yesPhilos Trans R Soc Lond B Biol Sci
Bates L   +4 more
europepmc   +1 more source

Single‐cell sequencing reveals the role of IL‐33+ endothelial subsets in promoting early gastric cancer progression

open access: yesiMeta, EarlyView.
A single‐cell atlas was established to reveal the molecular characteristics of early gastric cancer (EGC). In combination with organoids, animal models, and clinical samples, it was found that subpopulations such as pit mucous‐like cell (PMC‐like), proliferating cell (PC), CH25H+ CD4+ T cell, IL‐33+ endothelial cell, and ADAMTSL2+ endothelial cell are ...
Li Zhou   +15 more
wiley   +1 more source

Natural Language Processing for Chest X‐Ray Reports in the Transformer Era: BERT‐Like Encoders for Comprehension and GPT‐Like Decoders for Generation

open access: yesiRADIOLOGY, EarlyView.
We conducted a comprehensive literature search in PubMed to illustrate the current landscape of transformer‐based tools from the perspective of transformer's two integral components: encoder exemplified by BERT and decoder characterized by GPT.
Han Yuan
wiley   +1 more source

Population Pharmacokinetics and Exposure–Response Relationships of Etrolizumab in Patients with Moderately‐to‐Severely Active Crohn's Disease

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract This study aimed to characterize the pharmacokinetics (PK) of etrolizumab, an IgG1‐humanized monoclonal anti‐β7 integrin antibody, and assess its exposure–response (ER) relationship for key clinical outcomes in patients with moderately‐to‐severely active Crohn's disease.
Anita Moein   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy